These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7342480)

  • 41. Secretin: a physiological regulator of gastric emptying and acid output in dogs.
    Jin HO; Lee KY; Chang TM; Chey WY; Dubois A
    Am J Physiol; 1994 Oct; 267(4 Pt 1):G702-8. PubMed ID: 7943335
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Experimental study on glucose turnover and amino acid metabolism after total pancreatectomy].
    Mishina T
    Nihon Geka Gakkai Zasshi; 1988 Apr; 89(4):568-75. PubMed ID: 3043166
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma-glucagon after pancreatectomy.
    Lancet; 1976 Jun; 1(7972):1290-1. PubMed ID: 73709
    [No Abstract]   [Full Text] [Related]  

  • 44. Response of gut glucagon-like immunoreactivity to hypoglycemia in dogs.
    Ohneda A; Sasaki I; Naito H; Toda M; Ohneda M; Koizumi F
    Am J Physiol; 1989 Mar; 256(3 Pt 1):E431-8. PubMed ID: 2646947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Persistence of immunoreactive insulin, glucagon and pancreatic polypeptide in the plasma of depancreatized chickens.
    Colca JR; Hazelwood RL
    J Endocrinol; 1982 Mar; 92(3):317-26. PubMed ID: 7040582
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triglyceride metabolism in acute starvation: the role of secretin and glucagon.
    Stout RW; Henry RW; Buchanan KD
    Eur J Clin Invest; 1976 Mar; 6(2):179-85. PubMed ID: 1261585
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of theophylline on glucagon and secretin stimulated bile flow.
    Kaminski DL; Deshpande YG
    Dig Dis Sci; 1984 Mar; 29(3):261-6. PubMed ID: 6697865
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Circulating glucagon after total pancreatectomy in man.
    Holst JJ; Pedersen JH; Baldissera F; Stadil F
    Diabetologia; 1983 Nov; 25(5):396-9. PubMed ID: 6653943
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased "glucagon immunoreactivity" in plasma of totally depancreatized dogs.
    Vranic M; Pek S; Kawamori R
    Diabetes; 1974 Nov; 23(11):905-12. PubMed ID: 4430418
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of the kidneys in elimination of glucagon, insulin, secretin and somatostatin in the rat.
    El Munshid HA; Holst JJ; Lundquist I; Lundqvist G; Schaffalitzky De Muckadell OB; Håkanson R
    Acta Physiol Scand; 1983 Jan; 117(1):27-31. PubMed ID: 6134426
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Modulatory effect of glucose, amino acids, and secretin on CCK-8-induced somatostatin and pancreatic polypeptide release in dogs.
    Schusdziarra V; Lenz N; Schick R; Maier V
    Diabetes; 1986 May; 35(5):523-9. PubMed ID: 2869995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of glucagon-(1-21)-peptide on secretin-stimulated pancreatic exocrine secretion in anesthetized dogs.
    Itoh H; Matsuyama T; Namba M; Watanabe N; Komatsu R; Kono N; Tarui S
    Life Sci; 1989; 44(12):819-25. PubMed ID: 2704290
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canine pancreatic endocrine function after interruption of pancreatic exocrine drainage.
    Bewick M; Miller BH; Compton FJ; Gonzales-Carillo M; Avgoustis A; Eaton B
    Transplantation; 1983 Sep; 36(3):246-51. PubMed ID: 6351366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glucagon and insulin release from the allografted canine pancreas.
    Brynger H; Claes G; Lernmark A
    Eur Surg Res; 1975; 7(3):170-80. PubMed ID: 1098914
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of the vagus nerve on release and action of secretin in dog.
    Chey WY; Kim MS; Lee KY
    J Physiol; 1979 Aug; 293():435-46. PubMed ID: 501615
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Extrapancreatic glucagon and glucagonlike immunoreactivity in depancreatized dogs. A quantitative assessment of secretion rates and anatomical delineation of sources.
    Muller WA; Girardier L; Seydoux J; Berger M; Renold AE; Vranic M
    J Clin Invest; 1978 Jul; 62(1):124-32. PubMed ID: 659625
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of glucagon on secretin-stimulated bile flow.
    Kaminski DL; Ruwart MJ; Jellinek M
    Am J Physiol; 1975 Dec; 229(6):1480-5. PubMed ID: 174445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired glucose-induced glucagon suppression after partial pancreatectomy.
    Schrader H; Menge BA; Breuer TG; Ritter PR; Uhl W; Schmidt WE; Holst JJ; Meier JJ
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2857-63. PubMed ID: 19491219
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of circulating immunoreactive glucagon in response to intraduodenal administration of fat in dogs.
    Ohneda A; Yanbe A; Maruhama Y; Ishii S; Kai Y; Abe R; Yamagata S
    Gastroenterology; 1975 Apr; 68(4 Pt 1):715-21. PubMed ID: 1123138
    [No Abstract]   [Full Text] [Related]  

  • 60. Effects of secretin antibody on gastric acid inhibition and pancreatic bicarbonate stimulation by acidified liver extract meal in dogs.
    Konturek SJ; Konturek JW; Domschke S; Domschke W; Varga L; Halter F
    Hepatogastroenterology; 1986 Aug; 33(4):170-5. PubMed ID: 3758909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.